Skip to content

Clinical trials

Completed Phase 1/2 Dementia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 1/2 Status: Completed Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20071
20081
20101
20122
20131
20141
20151
20193
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AC Immune SA1
Arizona State University1
BioXcel Therapeutics Inc1
Brigham and Women's Hospital1
Chinese University of Hong Kong1
Intra-Cellular Therapies, Inc.1
Johns Hopkins University1
Massachusetts General Hospital1
National Institute of Neurological Disorders and Stroke (NINDS)1
National University Hospital, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia19
Alzheimer Disease11
Cognitive Dysfunction5
Amyotrophic Lateral Sclerosis1
Anxiety Disorders1
Brain Diseases1
Central Nervous System Diseases1
Down Syndrome1
Hyperlipidemias1
Inflammation1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.